New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
07:04 EDTTHRXFDA panel vote on olodaterol positive for Theravance drug, says Piper Jaffray
Piper Jaffray believes the positive FDA panel recommendation for Boehringer's olodaterol in COPD signals a similar outcome for Theravance's Breo's panel on March 7. The firm recommends buying shares of Theravance ahead of the FDA panel and keeps an Overweight rating on the name with a $32 price target.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
05:25 EDTTHRXTheravance announces positive Anoro Ellipta study data published
Subscribe for More Information
October 9, 2014
16:09 EDTTHRXTheravance names Eric d'Esparbes as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use